Increased vascular permeability precedes cellular inflammation as asthma control deteriorates

Clinical and Experimental Allergy

Volumn 39, Issue 11, 2009, Pages 1659-1667

  Khor, Y H ^a,b   Teoh, A K Y ^a,b   Lam, S M ^a,b   Mo, D C Q ^a,b   Weston, S ^a,b   Reid, D W ^a,b   Walters, E H ^a,b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Asthma; Vascular endothelial growth factor; Vascular remodelling

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; FLUTICASONE PROPIONATE; METHACHOLINE; VASCULOTROPIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ASTHMA; BLOOD VESSEL PERMEABILITY; BRONCHOSCOPY; BRONCHUS BIOPSY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE CONTROL; DISEASE DURATION; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; INFLAMMATION; LUNG LAVAGE; MALE; PEAK EXPIRATORY FLOW; PRICK TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SKIN TEST; SPIROMETRY; STAINING; T LYMPHOCYTE; TREATMENT DURATION;

ADULT; ANDROSTADIENES; ASTHMA; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHODILATOR AGENTS; CAPILLARY PERMEABILITY; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; SERUM ALBUMIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70350320406     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2009.03349.x     Document Type: Article

References (53)

1. Li X, Wilson JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997 145 : 229 233.
2. Orsida BE, Ward C, Li X et al. Effect of a long-acting β2-agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med 2001 164 : 117 121.
3. + T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993 92 : 313 324.
4. Sulakvelidze I, Inman MD, Rerecich T, O'Byrne PM. Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics. Eur Respir J 1998 11 : 821 827.
5. Castro M, Bloch SR, Jenkerson MV et al. Asthma exacerbations after glucocorticoid withdrawal reflects T cell recruitment to the airway. Am J Respir Crit Care Med 2004 169 : 842 849.
6. Khor YH, Feltis BN, Reid DW et al. Airway cell and cytokine changes in early asthma deterioration after inhaled corticosteroid reduction. Clin Exp Allergy 2007 37 : 1189 1198.
7. In't Veen JCCM, Smits HH, Hiemstra PS, Zwinderman AE, Sterk PJ, Bel EH. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. Am J Respir Crit Care Med 1999 160 : 93 9.
8. Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000 161 : 64 72.
9. Leuppi JD, Salome CM, Jenkins CR et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med 2001 163 : 406 412.
10. Gelb AF, Taylor CF, Shinar CM, Gutierrez C, Zamel N. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest 2006 129 : 1492 1499.
11. Wilson J. The bronchial microcirculation in asthma. Clin Exp Allergy 2000 30 : 51 3.
12. McDonald DM. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 2001 164 : S39 45.
13. Black J, Page C. Airways and vascular remodelling in asthma and cardiovascular disease, implications for therapeutic intervention. Eur Respir J 1994 7 : 622 623.
14. Vrugt B, Wilson S, Bron A, Holgate ST, Djukanovic R, Aalbers R. Bronchial angiogenesis in severe glucocorticoid-dependent asthma. Eur Respir J 2000 15 : 1014 1021.
15. Tanaka H, Yamada G, Saikai T et al. Increased airway vascularity in newly diagnosed asthma using a high-magnification bronchovideoscope. Am J Respir Crit Care Med 2003 168 : 1495 1499.
16. Li X, Ward C, Thien F et al. An antiinflammatory effect of salmeterol, a long-acting β2 agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma. Am J Respir Crit Care Med 1999 160 : 1493 1499.
17. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995 152 : S77 121.
18. Orsida BE, Li X, Hickey B, Thien F, Wilson JW, Walters EH. Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax 1999 54 : 289 295.
19. Feltis BN, Wignarajah D, Zheng L et al. Increased vascular endothelial growth factor and receptors. Relationship to angiogenesis in asthma. Am J Respir Crit Care Med 2006 173 : 1201 1207.
20. Fick RB Jr., Metzger WJ, Richerson HB et al. Increased bronchovascular permeability after allergen exposure in sensitive asthmatics. J Appl Physiol 1987 63 : 1147 1155.
21. Salomonsson P, Gronneberg R, Gilljam H et al. Bronchial exudation of bulk plasma at allergen challenge in allergic asthma. Am Rev Respir Dis 1992 146 : 1535 1542.
22. Evans TW, Rogers DF, Aursudkij B, Chung KF, Barnes PJ. Inflammatory mediators involved in antigen-induced airway microvascular leakage in guinea pigs. Am Rev Respir Dis 1988 138 : 395 399.
23. Sertl K, Kowalski ML, Slater J, Kaliner MA. Passive sensitization and allergen challenge increase vascular permeability in rat airways. Am Rev Respir Dis 1988 138 : 1295 1299.
24. Olivenstein R, Du T, Xu LJ, Martin JG. Microvascular leakage in the airway wall and lumen during allergen induced early and late responses in rats. Pulm Pharmacol Ther 1997 10 : 223 230.
25. Laitinen LA, Robinson NP, Laitinen A, Widdicombe JG. Relationship between tracheal mucosal thickness and vascular resistance in dogs. J Appl Physiol 1986 61 : 2186 2193.
26. Corfield DR, Hanafi Z, Webber SE, Widdicombe JG. Changes in tracheal mucosal thickness and blood flow in sheep. J Appl Physiol 1991 71 : 1282 1288.
27. Orsida BE, Ward C, Li X et al. Effect of a long-acting β2-agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med 2001 164 : 117 121.
28. Belda J, Margarit G, Martinez C et al. Bronchial exudates of serum proteins during asthma attack. Arch Bronconeumol 2005 41 : 328 333.
29. Goldie RG, Pedersen KE. Mechanisms of increased airway microvascular permeability: role in airway inflammation and obstruction. Clin Exp Pharmacol Physiol 1995 22 : 387 396.
30. Yager D, Kamm RD, Drazen JM. Airway wall liquid: sources and role as an amplifier of bronchoconstriction. Chest 1995 107 : 105 110.
31. Persson CGA, Andersson M, Greiff L et al. Airway permeability. Clin Exp Allergy 1995 23 : 807 814.
32. Bellido-Casado J, Plaza V, Belda J, Martinez-Bru C, Torrejon M, Sanchis J. Swelling of the bronchial mucosa and quickness of onset in acute asthma. Med Clin (Barcelona) 2006 127 : 451 453.
33. Baluk P, Tammela T, Ator E et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 2005 115 : 247 257.
34. Persson CGA, Erjefalt JS, Andersson M, Greiff L, Svensson C. Extravasation, lamina propria flooding and luminal entry of bulk plasma exudates in mucosal defence, inflammation and repair. Pulm Pharmacol 1996 9 : 129 139.
35. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001 107 : 295 301.
36. Asai K, Kanazawa H, Kamoi H, Shiraishi S, Hirata K, Yoshikawa J. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy 2003 33 : 595 599.
37. Kanazawa H, Nomura S, Yoshikawa J. Role of microvascular permeability on physiologic differences in asthma and eosinophilic bronchitis. Am J Respir Crit Care Med 2004 169 : 1125 1130.
38. Van Rensen ELJ, Hiemstra PS, Rabe KF, Sterk PJ. Assessment of microvascular leakage via sputum induction. The role of substance P and neurokinin A in patients with asthma. Am J Respir Crit Care Med 2002 165 : 1275 1279.
39. Persson CGA. Plasma exudation in the airways: mechanisms and function. Eur Respir J 1991 4 : 1268 1274.
40. Erjefält JS, Erjefält I, Sundler F, Persson CGA. Epithelial pathways for luminal entry of bulk plasma. Clin Exp Allergy 1995 25 : 187 195.
41. Chetta A, Zanini A, Foresi A et al. Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone. Am J Resp Crit Care Med 2003 167 : 751 757.
42. Hoshino M, Takahashi M, Takai Y, Sim J, Aoike N. Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma. Clin Exp Allergy 2001 31 : 722 730.
43. Kanazawa H, Nomura S, Asai K. Roles of angiopoietin-1 and angiopoietin-2 on airway microvascular permeability in asthmatic patients. Chest 2007 131 : 1035 1041.
44. Piedimonte G, McDonald DM, Nadel JA. Glucocorticoids inhibit neurogenic plasma extravasation and prevent virus-potentiated extravasation in the rat trachea. J Clin Invest 1990 86 : 1409 1415.
45. Horvath G, Wanner A. Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma. Eur Respir J 2006 27 : 172 187.
46. Wanner A, Horvath G, Brieva JL et al. Nongenomic actions of glucocorticosteroids on the airway vasculature in asthma. Proc Am Thorac Soc 2004 1 : 235 238.
47. Kumar SD, Brieva JL, Danta I, Wanner A. Transient effect of inhaled fluticasone on airway mucosal blood flow in subjects with and without asthma. Am J Respir Crit Care Med 2000 161 : 918 921. (Pubitemid 30171752)
48. Barnes PJ. Effect of beta-agonists on inflammatory cells. J Allergy Clin Immunol 1999 104 : S10 7.
49. Hanania NA, Moore RH. Anti-inflammatory activities of beta2-agonists. Curr Drug Targets Inflamm Allergy 2004 3 : 271 277.
50. Broadley KJ. Beta-adrenoceptor responses of airways: for better or worse? Eur J Pharmacol 2006 533 : 15 27.
51. Basran GS, Hardy JG, Woo SP, Ramasubramanian R, Byrne AJ. Beta-2-adrenoceptor agonists as inhibitors of lung vascular permeability to radiolabelled transferrin in the adult respiratory distress syndrome in man. Eur J Nucl Med 1986 12 : 381 444.
52. Advenier C, Qian Y, LawKoune JD, Molimard M, Candenas ML, Naline E. Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea-pig. Br J Pharmacol 1992 105 : 792 798.
53. Sulakvelidze I, McDonald DM. Anti-edema action of formoterol in rat trachea does not depend on capsaicin-sensitive sensory nerves. Am J Respir Crit Care Med 1994 149 : 232 238.